News headlines about Strata Skin Sciences (NASDAQ:SSKN) have been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Strata Skin Sciences earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 44.6966502427035 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the news stories that may have impacted Accern’s rankings:

Several analysts have commented on the stock. ValuEngine upgraded shares of Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st. HC Wainwright restated a “buy” rating on shares of Strata Skin Sciences in a report on Thursday, September 7th. Finally, Zacks Investment Research downgraded shares of Strata Skin Sciences from a “hold” rating to a “sell” rating in a report on Thursday, November 16th.

Shares of Strata Skin Sciences (NASDAQ SSKN) remained flat at $$1.21 during mid-day trading on Thursday. The company had a trading volume of 57,500 shares, compared to its average volume of 120,679. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.07 and a current ratio of 1.64. Strata Skin Sciences has a 52 week low of $1.06 and a 52 week high of $5.40.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at

Strata Skin Sciences Company Profile

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Insider Buying and Selling by Quarter for Strata Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with's FREE daily email newsletter.